A detailed history of Center For Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Center For Asset Management LLC holds 1,944 shares of ABBV stock, worth $349,920. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,944
Previous 1,944 -0.0%
Holding current value
$349,920
Previous $333,000 15.02%
% of portfolio
0.23%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $23,528 - $27,475
-152 Reduced 7.25%
1,944 $333,000
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $40,274 - $45,889
-252 Reduced 10.73%
2,096 $381,000
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $48,572 - $54,704
-353 Reduced 13.07%
2,348 $363,000
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $158,036 - $182,950
1,183 Added 77.93%
2,701 $402,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $450,136 - $560,165
-3,397 Reduced 69.11%
1,518 $204,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $2,892 - $3,330
20 Added 0.41%
4,915 $783,000
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $47,716 - $57,225
345 Added 7.58%
4,895 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $16,373 - $18,779
-122 Reduced 2.61%
4,550 $611,000
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $326,572 - $415,180
2,373 Added 103.22%
4,672 $716,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $23,228 - $28,820
176 Added 8.29%
2,299 $373,000
Q4 2021

Jan 12, 2022

BUY
$107.43 - $135.93 $8,916 - $11,282
83 Added 4.07%
2,123 $287,000
Q3 2021

Nov 01, 2021

SELL
$106.4 - $120.78 $2,979 - $3,381
-28 Reduced 1.35%
2,040 $220,000
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $10,626 - $11,838
101 Added 5.13%
2,068 $233,000
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $5,728 - $6,306
56 Added 2.93%
1,967 $213,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $153,816 - $207,668
1,911 New
1,911 $205,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Center For Asset Management LLC Portfolio

Follow Center For Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center For Asset Management LLC with notifications on news.